Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Humanization for neurological disease modeling: A roadmap to increase the potential of Drosophila model systems. | Animal Model Exp Med | 2023 | 37323110 | PubTator, text mining | PubMed |
| Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia. | World J Hepatol | 2023 | 37305373 | PubTator, text mining | PubMed |
| A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations. | Diagn Pathol | 2023 | 37303048 | PubTator, text mining | PubMed |
| Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort. | Diagn Pathol | 2023 | 37301854 | PubTator, text mining | PubMed |
| 23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function. | Oncoimmunology | 2023 | 37288324 | PubTator, text mining | PubMed |
| A Study Based on Network Pharmacology Decoding the Multi-Target Mechanism of Duhuo Jisheng Decoction for the Treatment of Intervertebral Disc Degeneration. | Comput Intell Neurosci | 2023 | 37288170 | PubTator, text mining | PubMed |
| TL1A promotes the postoperative cognitive dysfunction in mice through NLRP3-mediated A1 differentiation of astrocytes. | CNS Neurosci Ther | 2023 | 37269079 | PubTator, text mining | PubMed |
| EPHB4-RASA1-Mediated Negative Regulation of Ras-MAPK Signaling in the Vasculature: Implications for the Treatment of EPHB4- and RASA1-Related Vascular Anomalies in Humans. | Pharmaceuticals (Basel) | 2023 | 37259315 | PubTator, text mining | PubMed |
| SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. | Front Immunol | 2023 | 37251372 | PubTator, text mining | PubMed |
| RAS-targeted cancer therapy: Advances in drugging specific mutations. | MedComm (2020) | 2023 | 37250144 | PubTator, text mining | PubMed |
| Activin A Limits VEGF-Induced Permeability via VE-PTP. | Int J Mol Sci | 2023 | 37240047 | PubTator, text mining | PubMed |
| Crosstalk between miRNAs and DNA Methylation in Cancer. | Genes (Basel) | 2023 | 37239435 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
| Expression and clinical significance of DOK3 in renal clear cell carcinoma. | J Int Med Res | 2023 | 37235715 | PubTator, text mining | PubMed |
| Effective long-term sirolimus treatment in hypoxemia mainly due to intrapulmonary right-to-left shunt in a patient with multiple vascular anomalies. | Orphanet J Rare Dis | 2023 | 37226169 | PubTator, text mining | PubMed |
| Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. | Signal Transduct Target Ther | 2023 | 37221195 | PubTator, text mining | PubMed |
| Actuation of single downstream nodes in growth factor network steers immune cell migration. | Dev Cell | 2023 | 37220748 | PubTator, text mining | PubMed |
| Structure learning for gene regulatory networks. | PLoS Comput Biol | 2023 | 37200395 | PubTator, text mining | PubMed |
| Bioengineered Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles as an Improved Drug Delivery System: Methods and Applications. | Biomedicines | 2023 | 37189850 | PubTator, text mining | PubMed |
| A census of actin-associated proteins in humans. | Front Cell Dev Biol | 2023 | 37187613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=16